Evidence map›Paper›PMID 34126765›Full record

ArticlemBio2021

A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa.

Nolan Neville, Nathan Roberge, Xiang Ji, Preyesh Stephen, Jiasheng Louis Lu, Zongchao Jia

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The roles and synthesis of inorganic polyphosphate inbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Journal of medical microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. mSphere · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nolan NevilleDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Nathan RobergeDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Xiang JiRisen (Shanghai) Pharma Tech Co., Ltd., Shanghai, China.
Preyesh StephenDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Jiasheng Louis LuRisen (Shanghai) Pharma Tech Co., Ltd., Shanghai, China.
Zongchao JiaDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Queen's University · CAChinese Academy of Sciences · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The opportunistic pathogen Pseudomonas aeruginosa is a leading cause of nosocomial infections, which are becoming increasingly difficult to treat due to antibiotic resistance. Polyphosphate (polyP) plays a key role in P. aeruginosa virulence, stress response, and antibiotic tolerance, suggesting an attractive drug target. Here, we show that the small molecule gallein disrupts polyphosphate homeostasis by inhibiting all members of both polyphosphate kinase (PPK) families (PPK1 and PPK2) encoded by P. aeruginosa, demonstrating dual-specificity PPK inhibition for the first time. Inhibitor treatment phenocopied

Indexed as

AnimalsAnti-Bacterial AgentsCaenorhabditis elegansEnzyme InhibitorsHEK293 CellsHumansPhenotypePhosphotransferases (Phosphate Group Acceptor)Pseudomonas aeruginosaPseudomonas InfectionsVirulenceXanthenesAnti-Bacterial AgentsEnzyme InhibitorsgalleinPhosphotransferases (Phosphate Group Acceptor)polyphosphate kinaseXanthenesCaenorhabditis elegansgalleininhibitorkinasepolyphosphatePseudomonas aeruginosavirulence

Identifiers

PMID34126765
PMCPMC8262977
OpenAlexW3172164606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.